Using Boarding Ring Glasses to Treat Vestibular Neuritis
Official title: Evaluation of the Efficacy of BOARDING RING Glasses in the Treatment of Vestibular Neuritis
Run by University Hospital, Brest · NCT04678167 · Data updated 2026-11-12
This study tests if wearing Boarding Ring glasses can help people with vestibular neuritis recover from vertigo faster than those who don’t wear the glasses.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 51 (estimated) |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 2 sites (Brest and 1 other locations) |
| Status | Recruiting |
| Started | March 10, 2021 |
| Main results expected | March 17, 2028 |
| Study ends | May 10, 2029 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT04678167 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults diagnosed with vestibular neuritis who experience continuous rotating vertigo and have specific clinical signs such as spontaneous nystagmus.
✕Probably not a fit
Patients with a history of vestibular vertigo lasting more than four days, associated hearing loss, or central ocular abnormalities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of Boarding Ring glasses in accelerating vestibular compensation for patients suffering from vestibular neuritis, a condition characterized by intense and prolonged vertigo. Participants will undergo various assessments, including caloric tests and measurements of nystagmus, to determine the impact of the glasses compared to placebo or no glasses. The study aims to provide insights into a potential non-invasive treatment option for this debilitating condition.
Why it matters
Potential benefit: If successful, this study could offer a new, effective treatment option for patients suffering from vestibular neuritis, potentially reducing their symptoms and improving their quality of life.
How similar studies have gone: While this approach is relatively novel, similar studies exploring non-invasive interventions for vestibular disorders have shown promise, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult patients, * patient with vestibular neuritis defined by appearance of continuous rotating vertigo with nausea * patient with spontaneous horizonto-rotating nystagmus beating towards the healthy ear * patient with a postural deviation towards the affected ear; * vestibular hyporeflexia measured at the caloric tests greater than 25% * patient who has given free, enlighten and written consent Exclusion Criteria: * patient with a history of vertigo of vestibular origin or with vertigo developing for more than 4 days * patient with associated hearing loss or tinnitus * patient with an motor ocular abnormality of central origin * patient refusal or inability to consent
Where it's running
-
CHU de Brest
Brest, France Recruiting -
CH Pays de Morlaix
Morlaix, France Terminated
Study contacts
- Principal investigator: Jean-Christophe LECLERE, Dr — University Hospital, Brest
- Study coordinator: Jean-Christophe LECLERE, Dr
- Email: jean-christophe.leclere@chu-brest.fr
- Phone: 02.98.22.33.78
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Unified care and integrated treatments for ADHD with substance use in prison settings
Aimed at people under correctional supervision who have ADHD and substance use disorder, this program tests a coordinated care approach to improve identification and support.
-
4D dynamic LAFOV FDG-PET to tell leftover cancer from post-radiation inflammation in head and neck squamous cell carcinoma
This study will test whether a 4D dynamic long‑axial‑field‑of‑view FDG‑PET scan can tell remaining head and neck squamous cell cancer from normal post‑radiation inflammation in adults about three months after finishing curative radiotherapy.
-
Imaging the anatomy of the eye socket (orbit)
This project looks at existing orbital imaging from adults to see how the eye muscles, optic nerve, and orbital fat are arranged.
-
Combining European cohort data to find biomarkers that guide treatment for venous thromboembolism
This project combines clinical, biological and imaging data from European patient cohorts to try to find biomarkers that predict clot recurrence, bleeding, or death in people with venous thromboembolism.
-
Deneo Kid: an app to coordinate rehabilitation care for children and young people with neuromotor disabilities
This project will test whether the Deneo Kid app helps children and young people (age 2–25), their families, and rehabilitation teams share information and coordinate care more easily over three months.
-
Joint tissue analysis to understand rare and immunotherapy-related inflammatory arthritis
This project tests whether analyzing joint biopsy tissue can reveal distinct immune features in adults with inflammatory arthritis linked to rare autoimmune diseases or caused by cancer immunotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.